DBVT Q3 2022 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$3M

Operating Income

-$20M

Net Income

-$17M

EPS (Diluted)

$-0.90

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$248M

Total Liabilities

$36M

Stockholders' Equity

$212M

Cash & Equivalents

$213M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$3M	-$1M	-150.2%
Operating Income	-$20M	-$26M	+21.9%
Net Income	-$17M	-$24M	+28.2%